D Gaziev
Overview
Explore the profile of D Gaziev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gaziev D, Galimberti M, Polchi P, Angelucci E, Giardini C, Baronciani D, et al.
Bone Marrow Transplant
. 2002 Feb;
29(1):1-8.
PMID: 11840137
From April 1981 to February 2000, 105 patients with chronic myeloid leukemia (CML) underwent BMT from HLA-identical related donors at a single center. Eighty-eight patients were in chronic phase (CP),...
2.
Gaziev D, Lucarelli G
Expert Opin Investig Drugs
. 2001 Apr;
10(5):909-23.
PMID: 11322865
Chronic graft-versus-host disease (cGvHD) continues to be the major problem in long-term survivors of allogeneic haematopoietic stem cell transplants and is the principal cause of morbidity and non-relapse mortality. Over...
3.
Gaziev D, Lucarelli G, Polchi P, Angelucci E, Galimberti M, Giardini C, et al.
Bone Marrow Transplant
. 2001 Mar;
27(1):45-51.
PMID: 11244437
We analyzed the results of a three or more drug combination as treatment for moderate or severe cGVHD developing after transplantation for thalassemia, in 45 patients with median age of...
4.
Gaziev D, Galimberti M, Lucarelli G, Polchi P, Giardini C, Angelucci E, et al.
Bone Marrow Transplant
. 2000 May;
25(8):815-21.
PMID: 10808201
Twenty-nine patients with thalassemia and a median age of 6 years (range 1.1-33 years) were given a BMT from an alternative donor. Six of the 29 donors were HLA-phenotypically identical...
5.
Erer B, Galimberti M, Lucarelli G, Giardini C, Polchi P, Baronciani D, et al.
Bone Marrow Transplant
. 2000 Apr;
25(7):745-9.
PMID: 10745260
Patients undergoing bone marrow transplantation are profoundly immunosuppressed as a result of their intensive myeloablative chemotherapy and are at high risk for opportunistic fungal infections mainly caused by Candida spp...
6.
Gaziev D, Galimberti M, Lucarelli G, Polchi P
Bone Marrow Transplant
. 2000 Apr;
25(7):689-96.
PMID: 10745252
Despite conventional and new therapies for the treatment of chronic GVHD (cGVHD), this syndrome continues to account for significant morbidity and mortality after allogeneic hematopoietic stem cell transplantation. With the...
7.
Gaziev D, Polchi P, Lucarelli G, Galimberti M, Sodani P, Angelucci E, et al.
Bone Marrow Transplant
. 2000 Jan;
24(12):1299-306.
PMID: 10627638
Thirty-two thalassemic patients with a median age of 7.7 years (range 3.4-26 years) were given a second HLA-identical related marrow transplant (BMT2) for graft failure. Four patients were in class...
8.
Gaziev D, Giardini C, Galimberti M, Lucarelli G, Angelucci E, Polchi P, et al.
Bone Marrow Transplant
. 1999 Aug;
24(3):253-7.
PMID: 10455362
In transfused patients with aplastic anemia, incidence of graft rejection remains significant. Seventeen transfused patients with severe aplastic anemia received BMT from HLA-identical sibling donors after conditioning with cyclophosphamide (CY,...
9.
Lucarelli G, Clift R, Galimberti M, Angelucci E, Giardini C, Baronciani D, et al.
Blood
. 1999 Feb;
93(4):1164-7.
PMID: 9949158
One hundred seven adult patients with thalassemia aged from 17 through 35 years and transplanted from HLA-identical siblings between November 1988 and September 1996 were evaluated on December 31, 1997....
10.
Angelucci E, Muretto P, Lucarelli G, Ripalti M, Baronciani D, Erer B, et al.
Ann N Y Acad Sci
. 1998 Jul;
850:288-93.
PMID: 9668550
After successful marrow transplantation (BMT) iron overload remains an important cause of morbidity in Thalassemia. After BMT, patients have normal erythropoiesis capable of producing a hyperplastic response to phlebotomy so...